Gallagher Neil bought SNDX
February 7, 2024 · Form 4 insider transaction
Gallagher Neil bought 13,125 shares of Syndax Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,125
Price
$0.00
Total value
N/A
InsiderGallagher Neil
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 7, 2024
Filing dateFebruary 9, 2024
Shares owned after47,813
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company.